INMB Stock Analysis: Buy, Sell, or Hold?
INMB - INmune Bio Inc. Common stock
$2.09
0.04 (2.21%)
▲
5d:
+9.16%
30d:
+0.72%
90d:
+42.81%
WAIT
LOW Confidence
Analysis Updated: Aug 12, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When INMB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: INMB shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: INMB shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: INMB is currently trading at $2.08, which is considered extended relative to its 30-day fair value range of $1.68 to $1.96.
Technical Outlook: Technically, INMB is in a strong downtrend. Immediate support is located at $1.69, while resistance sits at $2.19.
Market Sentiment: INMB scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.00 (+243.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INMB is in a strong downtrend. Immediate support is located at $1.69, while resistance sits at $2.19.
Market Sentiment: INMB scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.00 (+243.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.68 -
$1.96
Company Quality Score
23/100
(STRONG SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range (+6.4% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 243.1% below Wall St target ($7.00)
- WARNING: Composite score 23/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.68 -
$1.96
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.69
Resistance Level
$2.20
Current Trend
Strong Downtrend
Technical data as of
Aug 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.89
Wall Street Target
$7.00
(+243.1%)
Revenue Growth (YoY)
257.1%
Share & Embed Analysis
Last updated: August 13, 2026 12:53 PM ET
Data refreshes hourly during market hours. Next update: 1:53 PM
Data refreshes hourly during market hours. Next update: 1:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INMB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 64 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$559 | 35 SELL |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 36 SELL |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$198 | 28 SELL |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 50 HOLD |
